Arcturus Therapeutics Ltd. Interest Expense
Arcturus Therapeutics Ltd. reported Interest Expense of $0 for the 9-month period ending 2018-09-30, per its 6-K filed 2018-11-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-11-07
- Arcturus Therapeutics Ltd. interest expense for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Arcturus Therapeutics Ltd. interest expense for the quarter ending 2017-12-31 was $12.00K.
- Arcturus Therapeutics Ltd. interest expense for the quarter ending 2017-09-30 was $135.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed | Interest Expense 71 month |
|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $0.00 6-K · filed 2018-11-07 | ||||
| 2018-06-30 | $0.00 6-K · filed 2018-09-28 | |||||
| 2017-12-31 | $12.00K derived: 20-F 12 month − 6-K 9 month · filed 2018-05-14 | $147.00K derived: sum of 2 quarters · filed 2018-11-07 | $150.00K 20-F · filed 2018-05-14 | |||
| 2017-09-30 | $135.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $138.00K 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | $3.00K 6-K · filed 2018-09-28 | |||||
| 2016-12-31 | $295.00K 20-F · filed 2018-05-14 | $161.00K 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | $251.00K 20-F · filed 2018-05-14 | $38.00K 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | $12.00K 20-F · filed 2017-04-28 | |||||
| 2013-12-31 | $219.00K 20-F · filed 2016-03-04 | $441.00K 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | $80.00K 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | $44.00K 20-F · filed 2014-03-28 |